-
Most Commented
- Cubadebate opens its new Web page in English | 20
- Mandela is dead: Why hide the truth about Apartheid? | 11
- El Paso Diary: The Battle Over the Solo Fax | 10
- President Hugo Chavez's address to the People of Venezuela | 10
- Free the Five is heard at Left Forum | 6
- The Unsustainable Position of the Empire | 5
- U.S. government promoting Internet aggression against Cuba | 5
- NATO’s Genocidal Role | 4
- The Fiftieth Anniversary Parade | 4
- Nato’s Fascist War | 4
- The Wonderful World of Capitalism | 4
- A Brilliant and Courageous Statement | 3
Series
- Cuba's Reasons
- Cuban Five
- El Paso Diary
The El Paso Diary is written by José Pertierra--an attorney who represents the government of Venezuela in its request for the extradition of Luis Posada Carriles. Pertierra´s journals describe the testimony, evidence, legal skirmishes, quirks and follies of this very historic trial that features for the first time the close collaboration of the United States government with Cuban authorities to prosecute an ex CIA agent who is one of the masterminds of the fifty-year old dirty war against Cuba.
Authors
- Bernie Dwyer
- Bruno Rodríguez Parrilla
- Deisy Francis Mexidor
- Fidel Castro Ruz
- José Pertierra
- Raúl Castro Ruz
- Ricardo Alarcón de Quesada
- Amy Goodman
- Arleen Rodríguez Derivet
- Frei Betto
- Hugo Chávez Frías
- Josh R. Nelson
- Juan Gelman
- Luis Rumbaut
- Michael Moore
- Mumia Abu-Jamal
- Noam Chomsky
- Reinaldo Taladrid Herrero
- Richard Gott
- Tom Hayden
Articles of Biotechnology
News »
Efficiency: a challenge for the pharmaceutical industry
To ensure stability in the basic supply of medications and reduce shortages, on April 8, President Miguel Díaz-Canel Bermúdez called for greater efforts to replace imports with domestic products and incorporate new ones; diversify markets and meet with export projections; while strengthening the investment process – despite the complex financial context – to increase productive capacity.
News »
A new milestone in Cuban biotechnology
The development of Cuban biotechnology has reached another important milestone with the recent signing of an agreement to establish a Cuba-United States joint venture enterprise to produce and distribute a therapeutic cancer medication.